Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emanuele Cozzani

Showing results (1-10 of 256) with videos related to

Pageof 26
Sort By:
Clinical Case Reports|October 22, 2020
H Syndrome retrospectively diagnosed: The importance of recognizing cutaneous signsAurora Parodi, Emanuele Cozzani
Medical Hypotheses|July 12, 2020
Coronavirus disease 2019 (COVID 19) and Malaria: Have anti glycoprotein antibodies a role?Aurora Parodi, Emanuele Cozzani
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|April 20, 2019
Skin diseases in pregnancy: a challenge for dermatologistsEmanuele Cozzani, Clara De Simone
Journal of Dermatological Case Reports|September 3, 2011
A case of psoriasis worsened by atorvastatinEmanuele Cozzani, Manuela Scaparro, Aurora Parodi
Journal of the American Academy of Dermatology|June 8, 2020
Could antiphospholipid antibodies contribute to coagulopathy in COVID-19?Aurora Parodi, Giulia Gasparini, Emanuele Cozzani
The Journal of Dermatological Treatment|July 21, 2006
Secondary cutaneous effects of hydroxyurea: possible pathogenetic mechanismsElisa Zaccaria, Emanuele Cozzani, Aurora Parodi
The Journal of Dermatological Treatment|July 21, 2006
Cutaneous adverse effects during therapy with an epidermal growth factor receptor (EGFR) inhibitorFrancesca Santoro, Emanuele Cozzani, Aurora Parodi
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|October 30, 2015
Topical treatment of actinic keratosis with 3.0% diclofenac in 2.5% hyaluronan gel: review of the literature about the cumulative evidence of its efficacy and safetySanja Javor, Emanuele Cozzani, Aurora Parodi
Cytokine|August 11, 2019
Interleukin-4 and interleukin-13 as possible therapeutic targets in systemic sclerosisGiulia Gasparini, Emanuele Cozzani, Aurora Parodi
International Journal of Dermatology|December 13, 2005
Bullous pemphigoid with nail lossFrancesco Gualco, Emanuele Cozzani, Aurora Parodi
Pageof 26

Showing results (1-10 of 256) with videos related to

Sort By:
Pageof 26
Clinical Case Reports|October 22, 2020
H Syndrome retrospectively diagnosed: The importance of recognizing cutaneous signsAurora Parodi, Emanuele Cozzani
Medical Hypotheses|July 12, 2020
Coronavirus disease 2019 (COVID 19) and Malaria: Have anti glycoprotein antibodies a role?Aurora Parodi, Emanuele Cozzani
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|April 20, 2019
Skin diseases in pregnancy: a challenge for dermatologistsEmanuele Cozzani, Clara De Simone
Journal of Dermatological Case Reports|September 3, 2011
A case of psoriasis worsened by atorvastatinEmanuele Cozzani, Manuela Scaparro, Aurora Parodi
Journal of the American Academy of Dermatology|June 8, 2020
Could antiphospholipid antibodies contribute to coagulopathy in COVID-19?Aurora Parodi, Giulia Gasparini, Emanuele Cozzani
The Journal of Dermatological Treatment|July 21, 2006
Secondary cutaneous effects of hydroxyurea: possible pathogenetic mechanismsElisa Zaccaria, Emanuele Cozzani, Aurora Parodi
The Journal of Dermatological Treatment|July 21, 2006
Cutaneous adverse effects during therapy with an epidermal growth factor receptor (EGFR) inhibitorFrancesca Santoro, Emanuele Cozzani, Aurora Parodi
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|October 30, 2015
Topical treatment of actinic keratosis with 3.0% diclofenac in 2.5% hyaluronan gel: review of the literature about the cumulative evidence of its efficacy and safetySanja Javor, Emanuele Cozzani, Aurora Parodi
Cytokine|August 11, 2019
Interleukin-4 and interleukin-13 as possible therapeutic targets in systemic sclerosisGiulia Gasparini, Emanuele Cozzani, Aurora Parodi
International Journal of Dermatology|December 13, 2005
Bullous pemphigoid with nail lossFrancesco Gualco, Emanuele Cozzani, Aurora Parodi
Pageof 26